Oscar Health, Inc. (OSCR) FY2026 YTD Q2 P&L / Income Statement
2026-01-01 to 2026-06-30
Revenue by Product and Service
2026-01-01 to 2026-06-30
Swipe to see the full flow
Chart details
Oscar Health, Inc. (OSCR) FY2026 YTD Q2 P&L / Income Statement
Income statement for 2026-01-01 through 2026-06-30. View: Revenue categories. Revenue uses this breakdown; costs and expenses retain the consolidated categories.
- Total revenue
- 9,527,414,000 US dollars
- Total operating expenses
- 8,434,694,000 US dollars
- Earnings (loss) from operations
- 1,092,720,000 US dollars
- Other income (expense), net (calculated)
- negative 10,936,000 US dollars
- Earnings (loss) before income taxes
- 1,081,784,000 US dollars
- Income tax expense (benefit)
- 40,933,000 US dollars
- Net income (loss)
- 1,040,851,000 US dollars
- Premium
- 9,370,193,000 US dollars
- Investment income
- 145,408,000 US dollars
- Other revenues
- 11,813,000 US dollars
- Medical
- 7,024,302,000 US dollars
- Depreciation and amortization
- 13,078,000 US dollars
- Selling, general, and administrative
- 1,397,314,000 US dollars
Chart connections
- Revenue minus operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
- Of which attributable to Oscar Health, Inc.: $1.04 B; to noncontrolling interests: $47.00 K.

Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG
Operating margin
11.5%
Operating profit / revenue
Cash conversion
452.6%
Operating cash / net income, same period
Product waitlist
Health Check and Teardown for your own company
A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!
